7th November 2016
Innovative biotechnology company, Axim Biotechnologies Inc has appointed Grayling in the US to support its Investor Relations and Public Relations’ needs.
Axim Biotechnologies is engaged in the research and development, and production of pharmaceutical, nutriceutical and cosmetic products, as well as the procurement of genetically and nano-controlled active ingredients. The company’s particular focus is on the development of treatments for pain, spasticity, anxiety and other medical disorders using cannabinoids-based products. Pharmaceutical R&D aims to deliver systems and active pharmaceutical ingredients for treating conditions such as Parkinson's disease, Alzheimer's disease, restless leg syndrome and Crohn's disease.
Presently, the company is conducting clinical studies of MedChewRx, a pharmaceutical chewing gum containing cannabinoids. The company is in the process of getting FDA and EMA regulatory approval to launch this product in 2017, and it is in regard to this that Grayling is providing support.
Grayling’s efforts will be driven by New York based executive vice president, Lucia Domville. She says: “This is a fascinating company that is really pushing the boundaries with its research, and we are thrilled to be their partner.”
30th January 2017
New Leadership for Grayling San Francisco
Grayling has appointed Bay Area veteran, Alan Dunton to run its San Francisco office. He takes over from Danica Ross, who assumes the new role of Chief Client Officer, with a US-wide remit.Dunton has...Read More
30th January 2017
New I.R. Brief for Grayling New York
Brazilian-owned industrial conglomerates company, Votorantim has appointed Grayling to handle its eighth Annual Investor Day in New York.This important event in the company’s calendar will see...Read More
17th November 2016
Double Award Win for Grayling Los Angeles
Grayling has picked up two trophies at the Public Relations Society of America (LA Chapter) PRism Awards. Both awards are in reconition of the team's work with Chinese backed electric vehicle...Read More